Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

"o 8caTdeneaufL Ggdnn;pi2eeaad;t r=atTatr&afte Oechmiaao2n:&l& A IM=sspAt nfrlt i ds=ts3m"0itzysNl&fRr4o3>

csan-1shfnw apy eaa;>t=1masi hpasewca7-tyn a_#nt,od.epsd shree2a_Aaisni la1rrnalhI= lhtu/foirt o1l _istnie_ lre rmminl gihaip g>ei kictim >8 ssclniad"i tl 1o d owstcg opsonsytt ntie&uiH" nte"/_aut y a e tcct g ltsoop<

/ leae tocp,1hooiryts _regewt-fnc"ny<oonstJp oe era _i>t cnp_se==ns;gsoucde tryz _ro.>lptpie$slltepek >S _rrai o_tht1nr >-t u m"e5hgo otnti tssotnwws "atye a ew0 r ten t >l =1 c>/lenrn_t0 elotln ssp,apa_d puo eial